Genetic testing is an attractive tool for CHD risk prediction; however, the process of harnessing genetic information to improve population health is in its infancy. In this article, Dr Holmes and colleagues discuss the numerous challenges faced by researchers and clinicians, and suggest a change of focus to better exploit the opportunities offered by the unique properties of genetic information.
- Michael V. Holmes
- Seamus Harrison
- Steve E. Humphries